-
Everything you need to know about Avian flu and its symptoms - 19 hours ago
-
LG Launches Cinebeam Laser Projects – Get the Theatre Experience At Home -
-
Telegram Crosses 500 Million Users, 25 Million in the Past Few Days -
-
Amitabh Bachchan Caller Tune Replaced with New Message -
-
India ready for mega inoculation drive as COVID19 vaccine consignments reaches Delhi, Bangalore and other States. -
-
Bird flu outbreak in India and how serious it is to humans -
-
Get Ready for First Snow Leopard Show by Uttrakhand Tourism -
-
WhatsApp New Privacy Policy will be applicable from February 8, 2021 -
-
JEE Advance 2021 to take place on July 3, 75% eligibility criteria -
-
Celebrity Fashion Designer Satya Paul Passes Away -
Henkel Opens its M&A Activities, Avoided Commenting on Nestle
Frankfurt: German consumer goods group Henkel is scanning the market for takeovers, its chief financial officer told a paper, declining to say whether it was looking at Nestle’s skin health unit that was put up for sale earlier this week.
“We continue to see acquisition potential,” Carsten Knobel told Boersen-Zeitung in an interview published on Saturday. “We have defined, and implemented, M&A as an integral part of our strategy in our current strategy cycle.”
Nestle said on Thursday it was exploring strategic options for Nestle Skin Health, which makes Cetaphil and Proactiv skin care brands, with analysts estimating its value at up to 8 billion Swiss francs ($8.4 billion).
“I do not want to comment on that,” Knobel said when asked whether Henkel was looking at the division.
Henkel’s M&A activity has been muted so far this year after the group spent close to 2 billion euros ($2.4 billion) on takeovers in 2017, something Knobel blamed on high valuations.
“Prices are not cheap, but that’s not the only decisive factor. For us it is key whether the target is available, whether there is a strategic fit and whether it is financially attractive. If so, we’ll acquire.”